Table 11.
Relationship among cell-function classification, metastasis and sex of patients with gastric carcinoma
| Types |
Liver metastasis |
Ovary metastasis | |
| Male (%) | Female (%) | ||
| AFDT | 9/66 (13.6)a | 0/16 | 0/16 |
| MSFDT | 0/39 | 1/15 (6.7) | 2/15 (13.3) |
| AMPFDT | 1/118 (0.8) | 0/62 | 12/62 (19.4)b |
| SFDT | 1/10 (10.0) | 0/3 | 0/3 |
| NFDT | 0/25 | 0/7 | 0/7 |
| Total | 11/258 (4.3) | 1/103 (1.0) | 14/103 (13.6) |
a
P < 0.01 (Exact test χ2 = 8.9527), vs AMPFDT of the male with liver metastasis;
b
P < 0.05 (Exact test χ2 = 4.2992), vs AFDT, SFDT and NFDT of the female with ovary metastasis.